OSTX

OS Therapies Incorporated Common Stock (OSTX)

About OS Therapies Incorporated Common Stock (OSTX)

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Grasonville, MD.

Details

Daily high
$1.58
Daily low
$1.49
Price at open
$1.57
52 Week High
$7.00
52 Week Low
$1.12
Market cap
34.0M
Dividend yield
0.00%
Volume
50,846
Avg. volume
145,814
P/E ratio
-3.03

OS Therapies Incorporated Common Stock News

Details

Daily high
$1.58
Daily low
$1.49
Price at open
$1.57
52 Week High
$7.00
52 Week Low
$1.12
Market cap
34.0M
Dividend yield
0.00%
Volume
50,846
Avg. volume
145,814
P/E ratio
-3.03